BIOMERICA INC (BMRA)
About BIOMERICA INC
Biomerica Inc is engaged in the development, manufacturing, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The company focuses on products for gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. The Company manages its operations as a single operating and reportable segment, which focus on the development, manufacture, marketing, and sale of diagnostic products. The majority of the company's revenue is earned from the Asia, and also has its presence in Europe, North America, Middle East and South America.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2025
- $5.3M
- Net income
- -$5.0M
- Total assets
- $5.9M
- Market cap
- $6.6M
- Gross margin
- 9.4%
- Operating margin
- -96.7%
- Net margin
- -93.6%
Source: SEC EDGAR · updated Jun 7, 2026
Revenue & profit trend
Financial statements
Income statement
- Revenue
- $5.3M
- Cost of revenue
- $4.8M
- Gross profit
- $498.0K
- Operating expenses
- $5.6M
- Operating income
- -$5.1M
- Income tax
- $1.0K
- Net income
- -$5.0M
- EPS (basic)
- $-2.16
- EPS (diluted)
- $-2.16
Balance sheet
- Total assets
- $5.9M
- Current assets
- $4.9M
- Total liabilities
- $1.8M
- Current liabilities
- $1.7M
- Shareholders’ equity
- $4.1M
Cash flow
- Operating cash flow
- -$3.8M
- Investing cash flow
- -$37.0K
- Financing cash flow
- $2.1M
- Net cash flow
- -$1.8M
Statements via Polygon.io (SEC filings)
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $6.6M
- EPS (diluted)
- $-2.16
- Shares outstanding
- 4.1M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Sep 26, 1978
Biomerica Inc (BMRA) Stock Price
- Reported a net loss of $5.0M in FY2025.
- Revenue declined 21% from FY2020 to FY2025.
- Gross margin of 9.4%, net margin -93.6%.
- Trading 62% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review BIOMERICA INC.
Write a review
News about BIOMERICA INC
News & sentiment via Polygon.io
Biomerica Inc: frequently asked questions
Is Biomerica Inc an American company?
Biomerica Inc is a US-based company headquartered in Irvine, California, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is Biomerica Inc headquartered?
Biomerica Inc is headquartered in Irvine, California, United States.
Is Biomerica Inc publicly traded?
Yes — Biomerica Inc is a publicly traded company. Its stock trades under the ticker symbol BMRA on the NASDAQ.
What does Biomerica Inc do?
Biomerica Inc is an American Medical Devices company in the Health & Beauty sector.
